1-(2-bromoethyl)-1H-benzo[c,d]indol-2-one | 131729-14-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 1-(2-bromoethyl)-1H-benzo[c,d]indol-2-one
• 英文别名: 1-(2-bromoethyl)benzo[cd]indol-2(1H)-one；1-(2-Bromoethyl)benzo[cd]indol-2-one
• CAS: 131729-14-1
• 化学式: C₁₃H₁₀BrNO
• 分子量: 276.132
• InChiKey: IMSSWRAHOJZYMR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-(2-bromoethyl)-1H-benzo[c,d]indol-2-one 在 potassium carbonate 、 一水合肼 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 12.0h， 生成 1-(2-aminoethyl)benzo[cd]indol-2(1H)-one
  参考文献：
  名称：

  Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-N-Acetyl-d-hexosaminidase

  摘要：

  Human beta-N-acetyl-D-hexosaminidase has gained much attention due to its roles in several pathological processes and been considered as potential targets for disease therapy. A novel and efficient skeleton, which was an unsymmetrical dyad containing naphthalimide and methoxyphenyl moieties with an alkylamine spacer linkage as a noncarbohydrate-based inhibitor, was synthesized, and the activities were valuated against human beta-N-acetyl-D-hexosaminidase. The most potent inhibitor exhibits high inhibitory activity with K-i values of 0.63 mu M. The straightforward synthetic manner of these unsymmetrical dyads and understanding of the binding model cold be advantageous for further structure optimization and development of new therapeutic agents for Hex-related diseases.

  DOI：

  10.1021/ml300475m
• 作为产物：
  描述：

  1,8-萘内酰亚胺 、 1,2-二溴乙烷 在 氢氧化钾 、 1-氢溴酸丁胺,1-溴化丁基铵,n-溴化丁铵 作用下， 以 苯 为溶剂， 反应 72.0h， 以18%的产率得到1-(2-bromoethyl)-1H-benzo[c,d]indol-2-one
  参考文献：
  名称：

  新的1-（杂环烷基）-4-（丙酰胺基）-4-哌啶基甲基酯和亚甲基甲基醚镇痛药。

  摘要：

  已经合成了一系列新的1-（杂环烷基）-4-（丙酰胺基）-4-哌啶基甲基酯和亚甲基甲基醚，并进行了药理学评估。在小鼠热板试验中，大多数化合物的镇痛效果（ED50低于1 mg / kg）优于吗啡。这些研究表明，与原型甲基酯（卡芬太尼，2）和亚甲基甲基醚（舒芬太尼，3和阿芬太尼，4）4的芳基乙基的相应组分相比，其结构上更多样化和更庞大的芳环体系具有药理学适应性4-丙酸安宁镇痛药。表现出明显的阿片类受体亲和力的化合物9A（1- [2-（1H-吡唑-1-基）-乙基] -4-[（1-氧丙基）苯基氨基] -4-哌啶羧酸甲酯）强效和短效止痛药，比阿芬太尼具有更少的大鼠呼吸抑制作用。另一方面，邻苯二甲酰亚胺57A和57B对与伤害性传递的介导相关的阿片受体（例如，mu-，kappa-和delta-亚型）表现出微不足道的亲和力，在所有抗伤害感受试验中均显示出镇痛效果。此外，尽管57B与临床阿片类药物相比，在大鼠

  DOI：

  10.1021/jm00106a051

文献信息

• New 1-(heterocyclylalkyl)-4-(propionanilido)-4-piperidinyl methyl ester and methylene methyl ether analgesics
  作者：Jerome R. Bagley、Sheela A. Thomas、Frieda G. Rudo、H. Kenneth Spencer、Brian M. Doorley、Michael H. Ossipov、Thomas P. Jerussi、Mark J. Benvenga、Theodore Spaulding

  DOI：10.1021/jm00106a051

  日期：1991.2

  bulkier aromatic ring systems than the corresponding components of the arylethyl groups of the prototypic methyl ester (carfentanil, 2) and methylene methyl ether (sufentanil, 3 and alfentanil, 4) 4-propionanilido analgesics. Compound 9A (methyl 1-[2-(1H-pyrazol-1-yl)-ethyl]-4-[(1-oxopropyl)phenylamino]-4- piperidinecarboxylate), which exhibited appreciable mu-opioid receptor affinity, was a more potent

  已经合成了一系列新的1-（杂环烷基）-4-（丙酰胺基）-4-哌啶基甲基酯和亚甲基甲基醚，并进行了药理学评估。在小鼠热板试验中，大多数化合物的镇痛效果（ED50低于1 mg / kg）优于吗啡。这些研究表明，与原型甲基酯（卡芬太尼，2）和亚甲基甲基醚（舒芬太尼，3和阿芬太尼，4）4的芳基乙基的相应组分相比，其结构上更多样化和更庞大的芳环体系具有药理学适应性4-丙酸安宁镇痛药。表现出明显的阿片类受体亲和力的化合物9A（1- [2-（1H-吡唑-1-基）-乙基] -4-[（1-氧丙基）苯基氨基] -4-哌啶羧酸甲酯）强效和短效止痛药，比阿芬太尼具有更少的大鼠呼吸抑制作用。另一方面，邻苯二甲酰亚胺57A和57B对与伤害性传递的介导相关的阿片受体（例如，mu-，kappa-和delta-亚型）表现出微不足道的亲和力，在所有抗伤害感受试验中均显示出镇痛效果。此外，尽管57B与临床阿片类药物相比，在大鼠
• Development of Unsymmetrical Dyads As Potent Noncarbohydrate-Based Inhibitors against Human β-<i>N</i>-Acetyl-<scp>d</scp>-hexosaminidase
  作者：Peng Guo、Qi Chen、Tian Liu、Lin Xu、Qing Yang、Xuhong Qian

  DOI：10.1021/ml300475m

  日期：2013.6.13

  Human beta-N-acetyl-D-hexosaminidase has gained much attention due to its roles in several pathological processes and been considered as potential targets for disease therapy. A novel and efficient skeleton, which was an unsymmetrical dyad containing naphthalimide and methoxyphenyl moieties with an alkylamine spacer linkage as a noncarbohydrate-based inhibitor, was synthesized, and the activities were valuated against human beta-N-acetyl-D-hexosaminidase. The most potent inhibitor exhibits high inhibitory activity with K-i values of 0.63 mu M. The straightforward synthetic manner of these unsymmetrical dyads and understanding of the binding model cold be advantageous for further structure optimization and development of new therapeutic agents for Hex-related diseases.
• Novel antitumor agent family of 1H-benzo[c,d]indol-2-one with flexible basic side chains: Synthesis and biological evaluation
  作者：Hong Yin、Yufang Xu、Xuhong Qian

  DOI：10.1016/j.bmc.2006.11.016

  日期：2007.2.1

  A series of mono-1H-benzo[c,d]indol-2-one with different amine side chains and bis-1H-benzo[c,d]indol-2-one as novel family of DNA intercalators were designed and synthesized, the contributions of aromatic chromophores and amine side chains for DNA binding properties, for example, intercalation and electrostatic binding, respectively, were evaluated. Among them, A3 tailed with N,N-dimethylamino-ethyl-ethane-1,2-diamine showed selective anti-tumor activities against cell lines A549 and P388 with IC50 0.428 mu m and 1.69 mu m. (c) 2006 Elsevier Ltd. All rights reserved.